Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ariella who wrote (950)	7/7/1998 8:41:00 AM
From: crysball	Read Replies (2) of 1491

Is Pharmos listening [reading]?? Zvi, Ariella, et al: Hopefully someone at Pharmos will contact the NIH investigators and provide them the published PARS data and current testing protocols for HU-211. It certainly would seem to appear NIH is "reinventing the wheel" From what was noted on the Yahoo PARS thread, Pharmos did extensive animal work on brain injury [response after crushing the frontal lobe etc], which would be far more indicative than mixing brain cells with Glutamate and Dex in a petri dish. Publish or Persish.........except Pharmos has already plowed this ground scientifically........perhaps PARS scientists aren't quite as adept in self promoting as the NIH staff.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next